Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Hester Biosciences Limited
  6. News
  7. Summary
    524669   INE782E01017

HESTER BIOSCIENCES LIMITED

(524669)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Hester Biosciences to Acquire 50% Stake in Tanzanian Animal Health Products Company

11/09/2021 | 06:35am EST


ę MT Newswires 2021
All news about HESTER BIOSCIENCES LIMITED
01/19CARE Maintains A- Rating on Hester Biosciences' Long-Term Bank Financing; Outlook Stabl..
MT
2021Hester Biosciences Limited Approves the Borrowings as a Loan by Way of External Commerc..
CI
2021Hester Biosciences to Acquire 50% Stake in Tanzanian Animal Health Products Company
MT
2021Hester Biosciences Limited agreed to acquire an 50% stake in Thrishool Exim Limited for..
CI
2021Hester Biosciences Limited Reports Earnings Results for the Second Quarter and Six Mont..
CI
2021Hester Biosciences Limited Announces Board Appointments
CI
2021HESTER BIOSCIENCES LIMITED(BSE : 524669) added to S&P Global BMI Index
CI
2021HESTER BIOSCIENCES' : Consolidated Profit More Than Doubles in Fiscal Q1
MT
2021Hester Biosciences to Seek Acquisitions
CI
2021Hester Biosciences Limited Announces Earnings Results for the First Quarter Ended June ..
CI
More news
Financials
Sales 2021 2 177 M 29,2 M 29,2 M
Net income 2021 344 M 4,62 M 4,62 M
Net Debt 2021 884 M 11,9 M 11,9 M
P/E ratio 2021 47,4x
Yield 2021 0,52%
Capitalization 20 465 M 275 M 275 M
EV / Sales 2020 4,74x
EV / Sales 2021 7,90x
Nbr of Employees 428
Free-Float 36,7%
Chart HESTER BIOSCIENCES LIMITED
Duration : Period :
Hester Biosciences Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 2 405,75 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Rajiv Dinesh Gandhi CEO, MD & Non-Independent Executive Director
Nikhil Jhanwar Chief Financial Officer
Bhupendra Vitthaldas Gandhi Non-Executive Chairman
Manish M. Bhatt Vice President-Engineering
Sumit Gupta Vice President-Information Technology
Sector and Competitors
1st jan.Capi. (M$)
HESTER BIOSCIENCES LIMITED-5.09%275
ZOETIS INC.-17.81%94 900
ELANCO ANIMAL HEALTH INCORPORATED-7.01%12 485
DECHRA PHARMACEUTICALS PLC-22.52%6 094
VIRBAC-7.66%3 756
JINYU BIO-TECHNOLOGY CO., LTD.-6.36%2 699